Comment On: “Stratifying Therapeutic Enoxaparin Dose in Morbidly Obese Patients by BMI Class: A Retrospective Cohort Study”
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s40261-020-00889-4.pdf
Reference5 articles.
1. Lee YR, Palmere PJ, Burton CE, Benavides TM. Stratifying therapeutic enoxaparin dose in morbidly obese patients by BMI class: a retrospective cohort study. Clin Drug Investig. 2019. https://doi.org/10.1007/s40261-019-00855-9.
2. van Oosterom N, Winckel K, Barras M. Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity. J Thromb Thromb. 2019;48(3):387–93. https://doi.org/10.1007/s11239-019-01847-4.
3. Monagle P, Michelson AD, Bovill E, Andrew M. Antithrombotic therapy in children. Chest. 2001;119(1):344S–70S. https://doi.org/10.1378/chest.119.1_suppl.344S.
4. Barras AM, Duffull BS, Atherton JJ, Green JB. Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrations. Ther Drug Monit. 2010;32(4):482–8. https://doi.org/10.1097/FTD.0b013e3181e64846.
5. Antman EM. Dose-ranging trial of enoxaparin for unstable angina: results of TIMI 11A 11A list of the participating investigators and clinical centers for the TIMI 11A trial appears in the Appendix A. J Am Coll Cardiol. 1997;29(7):1474–82. https://doi.org/10.1016/S0735-1097(97)00094-6.
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Response to Comment on: “Stratifying Therapeutic Enoxaparin Dose in Morbidly Obese Patients by BMI Class: A Retrospective Cohort Study”;Clinical Drug Investigation;2020-02-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3